These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3400268)

  • 41. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
    Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
    Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice.
    Fullerton FR; Greenman DL; Young JF
    Drug Metab Dispos; 1987; 15(5):602-7. PubMed ID: 2891474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacokinetics of AR-L 115 BS in the rat (author's transl)].
    Busch U
    Arzneimittelforschung; 1981; 31(1a):204-9. PubMed ID: 7195222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral absorption, metabolism and excretion of 1-phenoxy-2-propanol in rats.
    Saghir SA; Brzak KA; Bartels MJ
    Xenobiotica; 2003 Oct; 33(10):1059-71. PubMed ID: 14555341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract.
    Lei F; Xing DM; Xiang L; Zhao YN; Wang W; Zhang LJ; Du LJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):189-94. PubMed ID: 14552830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ellagitannins, ellagic acid and vascular health.
    Larrosa M; García-Conesa MT; Espín JC; Tomás-Barberán FA
    Mol Aspects Med; 2010 Dec; 31(6):513-39. PubMed ID: 20837052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute liver effects, disposition and metabolic fate of [
    Pickup K; Martin S; Partridge EA; Jones HB; Wills J; Schulz-Utermoehl T; McCarthy A; Rodrigues A; Page C; Ratcliffe K; Sarda S; Wilson ID
    Arch Toxicol; 2017 Jul; 91(7):2643-2653. PubMed ID: 27896398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Profiling and accurate quantification of Rubus ellagitannins and ellagic acid conjugates using direct UPLC-Q-TOF HDMS and HPLC-DAD analysis.
    Gasperotti M; Masuero D; Vrhovsek U; Guella G; Mattivi F
    J Agric Food Chem; 2010 Apr; 58(8):4602-16. PubMed ID: 20353173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ellagic acid metabolism and binding to DNA in organ explant cultures of the rat.
    Teel RW; Martin RM; Allahyari R
    Cancer Lett; 1987 Aug; 36(2):203-11. PubMed ID: 3621152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolism of beclamide after a single oral dose in man: quantitative studies.
    Ahmadi M; Nicholls PJ; Smith HJ; Spencer PS; Preet-Ryatt MS; Spragg BP
    J Pharm Pharmacol; 1995 Oct; 47(10):876-8. PubMed ID: 8583359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic studies with 3H-cytisine.
    Klöcking HP; Richter M; Damm G
    Arch Toxicol Suppl; 1980; 4():312-4. PubMed ID: 6933924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of [3H]equilin-[35S]sulfate and [3H]equilin sulfate after oral and intravenous administration in normal postmenopausal women and men.
    Bhavnani BR; Woolever CA; Wallace D; Pan CC
    J Clin Endocrinol Metab; 1989 Apr; 68(4):757-65. PubMed ID: 2921309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disposition and metabolism of the flavonoid chrysin in normal volunteers.
    Walle T; Otake Y; Brubaker JA; Walle UK; Halushka PV
    Br J Clin Pharmacol; 2001 Feb; 51(2):143-6. PubMed ID: 11259985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracellular Ellagic Acid Derived from Goat Urine DMSO Fraction (GUDF) Predicted as an Inhibitor of c-Raf Kinase.
    Raj AK; Lokhande KB; Prasad TK; Nandangiri R; Choudhary S; Pal JK; Sharma NK
    Curr Mol Med; 2024; 24(2):264-279. PubMed ID: 36642883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Collection of mouse urine or bile.
    Pope RS
    J Appl Physiol; 1967 May; 22(5):1024-5. PubMed ID: 6025741
    [No Abstract]   [Full Text] [Related]  

  • 58. [Variability of organic responses to intra-arterial administration of bile].
    RABINOVICH EL
    Arkh Patol; 1955; 17(3):62. PubMed ID: 13260023
    [No Abstract]   [Full Text] [Related]  

  • 59. An Overview of the Health Benefits, Extraction Methods and Improving the Properties of Pomegranate.
    Benedetti G; Zabini F; Tagliavento L; Meneguzzo F; Calderone V; Testai L
    Antioxidants (Basel); 2023 Jun; 12(7):. PubMed ID: 37507891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural Blockers of PD-1/PD-L1 Interaction for the Immunotherapy of Triple-Negative Breast Cancer-Brain Metastasis.
    Nakhjavani M; Shigdar S
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.